article thumbnail

Drug developers look at innovative mechanisms to tackle dry eye syndrome

Pharmaceutical Technology

Dry eye syndrome (DES) is an indication whose mainstay treatment has been dominated by Allergan’s Restasis (cyclosporine ophthalmic emulsion 0.05%) ever since its launch in 2003 in the US. NOV-03 is also likely to be well-received by physicians and patients due to its favorable clinical and tolerability profile.

article thumbnail

ChoiceSpine™ Announces Line Extension of their Harrier™ Stand-Alone Anterior Lumbar Interbody Fusion System

Legacy MEDSearch

By focusing on a collaborative team approach with physicians and industry partners, ChoiceSpine continues to deliver upon product commitments, maintain cutting-edge research and development, and bring technically superior products to the forefront of the spinal implant industry.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Healthcare Price Transparency is Here. Now What?

Clarify Health

Niall is the former Chief Data Officer of the Centers for Medicare & Medicaid (CMS), where he led groundbreaking efforts to release hospital and physician data for research, including the creation of the Virtual Research Data Center (VRDC) and Qualified Entity (QE) programs.

article thumbnail

Healthcare Price Transparency is Here. Now What?

Clarify Health

Niall is the former Chief Data Officer of the Centers for Medicare & Medicaid (CMS), where he led groundbreaking efforts to release hospital and physician data for research, including the creation of the Virtual Research Data Center (VRDC) and Qualified Entity (QE) programs.

article thumbnail

A Primer on Telepharmacy

Nixon Gwilt Law

And that’s because pharmacy is an incredibly important part of the healthcare ecosystem—for many patients, they see their pharmacist far more often than their primary care physician. Due to the success of the North Dakota Telepharmacy Project, the Board of Pharmacy in North Dakota permanently implemented telepharmacy regulations in 2003.

Medical 52
article thumbnail

Developing new treatment regimens for HIV

European Pharmaceutical Review

As a physician scientist with knowledge and experience in translational medicine and late-stage drug development, Sherene has a proven record in drug development including successful regulatory interactions with US and international agencies. References 1. World Health Organization. The Global Health Observatory. Internet] 2023.

article thumbnail

Market with Maximum Efficiency by Obeying Your Inner Sensei

PM360

Qualitative and quantitative research help pharma brand teams understand physician and patient attitudes, behaviors, and perspectives. When rosuvastatin entered the statin market in 2003, it faced the daunting challenge of competing against behemoths atorvastatin and simvastatin. Some of this urgency is inherent to the industry.